2023. Investigator global assessment (IGA) of Acne Vulgaris and IGA Success among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: PROSES study analysis by gender and age. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s156. DOI:https://doi.org/10.25251/skin.7.supp.156.